"General Electric/Honeywell — An insight into the Commission’s investigation and decision"* Owing to the benefits of engine commonality, incumbency of engine suppliers is better assessed in terms of the installed base of engines on aircraft that are still in production. Nevertheless, to the (...)
François Garnier was International Chief Counsel (outside the US) of Pfizer Inc. since January 2014. He joined Pfizer France, in April 2003, as Vice President, General Counsel before moving on to become Chief Counsel for Pfizer’s operations in Europe in January 2009, a position he held until January 2014. François Garnier began his career in March 1989 at Servier S.A. as International Contracts Manager and remained with the firm until September 1995. He then moved to Rhône Poulenc Rorer S.A. to take up the position of Counsel for Corporate Transactions. In May 1996, he moved to the United States as Associate Counsel, before being appointed Chief Counsel for France in May 1999. François Garnier continued his career as Chief Counsel at Aventis Animal Nutrition until September 2001, when he joined the Pharmacia Group as Chief Counsel for Europe. François Garnier has been appointed Executive Vice President, General Counsel for the Ipsen Group effective as of January 5, 2015.
13459 | Events
Considering the important number of contributions, the papers of this conference are reproduced in the pdf version attached only. Please note that these papers are also freely available for non-subscribers at the "Conference" section of the (...)
In order to examine whether it would be appropriate to develop or encourage the adoption of compliance programmes in France, the French Competition Council commissioned Europe Economics, in conjunction with Norton Rose, to conduct a study of compliance programmes. The conclusions of this study (...)